PYC Therapeutics Ltd - ESG Rating & Company Profile powered by AI
If you work at PYC Therapeutics Ltd and you wish to licence your Sustainability aseessment, please get in touch. This report of PYC Therapeutics Ltd was prepared by All Street Sevva using advanced NLP. This webpage includes a questions and answers table for PYC Therapeutics Ltd.
PYC Therapeutics Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.1; made up of an environmental score of 4.0, social score of 6.4 and governance score of 4.8.
5.1
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 687 | Valbiotis SA | 5.2 | High |
| 687 | Zeria Pharmaceutical Co Ltd | 5.2 | High |
| 724 | PYC Therapeutics Ltd | 5.1 | High |
| 724 | Catalyst Pharmaceuticals Inc | 5.1 | High |
| 724 | Adverum Biotechnologies Inc | 5.1 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does PYC Therapeutics Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes PYC Therapeutics Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes PYC Therapeutics Ltd report the average age of the workforce?
Sign up for free to unlockDoes PYC Therapeutics Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes PYC Therapeutics Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes PYC Therapeutics Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes PYC Therapeutics Ltd offer flexible work?
Sign up for free to unlockDoes PYC Therapeutics Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes PYC Therapeutics Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes PYC Therapeutics Ltd conduct supply chain audits?
Sign up for free to unlockDoes PYC Therapeutics Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes PYC Therapeutics Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes PYC Therapeutics Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes PYC Therapeutics Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes PYC Therapeutics Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes PYC Therapeutics Ltd disclose water use targets?
Sign up for free to unlockDoes PYC Therapeutics Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid PYC Therapeutics Ltd have a product recall in the last two years?
Sign up for free to unlockDoes PYC Therapeutics Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes PYC Therapeutics Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas PYC Therapeutics Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes PYC Therapeutics Ltd disclose parental leave metrics?
Sign up for free to unlockDoes PYC Therapeutics Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes PYC Therapeutics Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes PYC Therapeutics Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes PYC Therapeutics Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes PYC Therapeutics Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes PYC Therapeutics Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs PYC Therapeutics Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes PYC Therapeutics Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes PYC Therapeutics Ltd disclose its waste policy?
Sign up for free to unlockDoes PYC Therapeutics Ltd report according to TCFD requirements?
Sign up for free to unlockDoes PYC Therapeutics Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes PYC Therapeutics Ltd disclose energy use targets?
Sign up for free to unlockDoes PYC Therapeutics Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes PYC Therapeutics Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for PYC Therapeutics Ltd
These potential risks are based on the size, segment and geographies of the company.
PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia. The company's preclinical development programs include VP-001, drug program for retinitis pigmentosa type 11; and PYC-001, a drug program for the treatment of autosomal dominant optic atrophy. It also focuses on the development of programs for kidney, retinal, and central nervous system diseases. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to support drug discovery and development efforts in the field of neurodegenerative disorders, including Motor Neurone Disease. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.